心脏辅助装置 3 在心动脉错位矫正患者心脏移植桥接中的应用：一例报告。
Heartmate 3 as a bridge to heart transplantation in a patient with congenitally corrected transposition of the great arteries: a case report.
机构信息
The Division of Cardiovascular and Thoracic Surgery, Rabin Medical Center, Petach-Tikva, Israel.
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
出版信息
J Cardiothorac Surg. 2022 Mar 26;17(1):54. doi: 10.1186/s13019-022-01793-y.
BACKGROUND
We report the first use of Heartmate 3 (HM3) in a Congenitally corrected Transposition of the Great Arteries (ccTGA) as a Systemic Ventricular Assist Device (SVAD) to treat HF.
CASE PRESENTATION
A 55 years old man with a Congenitally corrected Transposition of the Great Arteries (ccTGA) a rare condition in which Heart Failure (HF) is a common presentation in adult life and survival without heart transplantation is hardly an option. Systemic Ventricular Assist Device (SVAD) can be an option if an organ does not become available. We present the first ever implantation of HM3 LVAD (Abbott Inc, Chicago IL) implanted to this patient as a bridge to transplantation, demonstrating the safety and feasibility of the procedure. Due to the unique mediastinal configuration, 3D cardiac CT reconstruction should be used for planning the procedure-intra ventricular placement of the inflow as well as mediastinal placemat of the outflow and pump.
CONCLUSIONS
This successful first use of HM3 as a SVAD for ccTGA patients, opens a novel treatment option for these patients as a bridge for heart transplant or as definitive treatment.
背景
我们报告了 Heartmate 3（HM3）在先天性矫正大动脉转位（ccTGA）中首次作为系统性心室辅助装置（SVAD）用于治疗心力衰竭（HF）的应用。
病例介绍
一位 55 岁男性患有先天性矫正大动脉转位（ccTGA），这是一种罕见的疾病，心力衰竭（HF）是成人生活中的常见表现，如果没有心脏移植，几乎没有生存的选择。如果没有器官可用，系统性心室辅助装置（SVAD）可能是一种选择。我们首次将 HM3 LVAD（雅培公司，芝加哥，IL）植入该患者，作为移植的桥梁，证明了该手术的安全性和可行性。由于独特的纵隔结构，应使用 3D 心脏 CT 重建来规划手术——心室内流入道的位置以及纵隔流出道和泵的位置。
结论
HM3 作为 ccTGA 患者的 SVAD 的首次成功应用，为这些患者提供了一种新的治疗选择，既可以作为心脏移植的桥梁，也可以作为确定性治疗。
Zotero 插件